JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'c-Abl'

Search results for: 'c-Abl'

A8236 Regorafenib

4 Citation

Target: Raf|VEGFR|PDGFR|c-Kit|RET

Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1

≥25.04 mg/mL
A4145 TG101209

Summary: JAK2/3 inhibitor

≥25.5 mg/mL
A8683 NVP-BHG712

Target: Eph Receptors|VEGFR

Summary: EphB4 inhibitor,potent and selective

≥25.15 mg/mL
B2171 Imatinib (STI571)

Target: PDGFR|c-Kit|Bcr-Abl

Summary: Protein-tyrosine kinase inhibitor

≥24.68 mg/mL
A8812 PD173955

Target: Bcr-Abl|Src

Summary: Dual Src/Abl kinase inhibitor, ATP-competitive,

≥22.15 mg/mL
B1011 Bafetinib (INNO-406)

2 Citation

Summary: Bcr-Abl/Lyn tyrosine kinase inhibitor

≥57.7 mg/mL
B1402 GZD824

Target: Bcr-Abl

Summary: Bcr-Abl inhibitor,novel orally bioavailable

≥36.25 mg/mL
A3527 Ki20227

Target: c-Fms tyrosine kinase

Summary: C-Fms tyrosine kinase inhibitor

≥48.1 mg/mL
A8347 Pazopanib Hydrochloride

Summary: VEGFR/PDGFR/FGFR/c-Kit/ c-Fms inhibitor

≥11.1 mg/mL
B1439 Golvatinib (E7050)

Target: VEGFR

Summary: C-Met/VEGFR-2 inhibitor